Search clinical trials for: Refractory Leukemia

Total 15500 results

Royal Marsden NHS Foundation Trust

Completed

Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours

Upper Gastrointestinal Tumours

United Kingdom
Dana-Farber Cancer Institute
Bristol-Myers Squibb; Massachusetts General Hospital; Beth Israel Deaconess Medical... and other collaborators

Completed

A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer

Prostate Cancer

United States
Sanofi

Completed

Docetaxel in the Treatment of Hormone Refractory Prostate Cancer

Prostatic Neoplasms

Czech Republic
Sanofi
Canadian Urologic Oncology Group

Completed

Docetaxel in Hormone Refractory Prostate Cancer (HRPC)[Weekly or 3weekly TAX + Prednisone in HRPC]

Prostatic Neoplasms
University of Sao Paulo

Unknown

Social Skills Training in Refractory Schizophrenia (SST)

Schizophrenia and Disorders With Psychotic Features

Brazil
European Society for Blood and Marrow Transplantation
Hoffmann-La Roche; Amgen

Completed

Peripheral Blood (PB) Versus Bone Marrow (BM) in Allogeneic Stem Cell Transplantation

Acute Leukemia | Myelodysplastic Syndrome | Chronic Myelogenous Leukemia

Germany
Novartis Pharmaceuticals

Completed

Gleevec Trial in Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

Chronic Myelogenous Leukemia

United States
Novartis

Completed

Efficacy, Safety and Long-term Prognosis of Imatinib in Patients Newly Diagnosed With Chronic Myelogenous Leukemia (Chronic Phase)

Chronic Myelogenous Leukemia in Chronic Phase
Novartis

Terminated

TKI258 in Subjects With Refractory or Relapsed Multiple Myeloma

Multiple Myeloma

United States
Bristol-Myers Squibb

Terminated

A Study of Dasatinib vs. High-Dose Imatinib (600 mg) in Patients With Chronic Phase Chronic Myeloid Leukemia (CML) Who Failed to Achieve Complete Cytogenetic Response After 3-18 Months of Imatinib Therapy

Leukemia

United States
University of Sao Paulo

Unknown

Identifying Predictors of Response to Antipsychotics Using a Treatment Algorithm

Schizophrenia or Schizoaffective Disorder

Brazil
Nantes University Hospital

Completed

Prospective Randomized Study Comparing One or Two High Dose Chemotherapy Regimen Followed by Autologous Stem Cell Transplantation (AML2001)

Acute Myeloid Leukemia

France
Wyeth is now a wholly owned subsidiary of Pfizer
PETHEMA (Program for the Study and Treatment of Haematological Malignances)

Completed

Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients

Lymphoma | Leukemia | Stem Cell Transplantation | Myelodysplasia | Myeloma | Hematological Malignancy

Spain
Genta Incorporated

Completed

Phase I/II Study of Genasense in Patients With Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia | CLL

United States
Myriad Therapeutics, Inc.

Terminated

Phase 1 Clinical Trial MPC-2130 Treatment of Blood Cancers / Refractory Cancer

Cancer

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham...

Completed

Evaluation of the Effects of Chemotherapy on the Uptake and Retention of Carbon 11 Methionine in Prostate Cancer Patients

Prostate Cancer

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Beth Israel Deaconess Medical Center; Genentech... and other collaborators

Completed

Tarceva and Capecitabine for Pancreatic Cancer

Neoplasm Metastasis | Pancreatic Cancer

United States
Cliniques universitaires Saint-Luc- Université...
Sanofi

Completed

Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer

Metastatic Prostate Cancer | Hormone Resistant Prostate Cancer

Belgium, Luxembourg
University of Vermont
St. Louis University

Completed

Safety Study of Nifurtimox for Relapsed or Refractory Neuroblastoma

Neuroblastoma

United States
Qualitix Clinical Research Co., Ltd.

Unknown

Trial of Mycophenolic Acid Versus Azathioprine in the Treatment of Corticosteroid-refractory Myasthenia Gravis (Myfortic)

Myasthenia Gravis
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)

Completed

Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor

Brain and Central Nervous System Tumors

United States
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Unknown

Intravitreal Injection Versus Sub-Tenon's Infusion of Triamcinolone Acetonide for Refractory Diabetic Macular Edema During Cataract Surgery

Diabetic Macular Edema

Brazil
Pfizer
European Society for Blood and Marrow Transplantation

Completed

Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants (VOSIFI)

Prophylaxis Of Invasive Fungal Infections

Portugal, Belgium, France, Germany, Spain, United Kingdom, Switzerland, Sweden
GlaxoSmithKline

Completed

Adefovir Dipivoxil In Compensated Chronic Hepatitis B Patients

Chronic Hepatitis B
Odense University Hospital
AstraZeneca; University of Southern Denmark; The Danish Medical Research Council and other collaborators

Completed

Proton Pump Inhibitor Treatment Stop

Dyspepsia

Denmark
Sanofi

Completed

Rasburicase as a Uricolytic Therapy for Hyperuricemia in Patients With Leukemia or Lymphoma

Lymphoma | Leukemia | Hyperuricemia

Japan
Sanofi

Completed

Japanese Study of the Combined Administration of Docetaxel With Prednisolone for Metastatic Hormone Refractory Prostate Cancer

Therapy, Prostatic Neoplasms

Japan
Nordic Society for Pediatric Hematology and Oncology
Danish Child Cancer Foundation; Medac, Hamburg, Germany

Unknown

Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses

Acute Lymphoblastic Leukemia

Denmark
Sun Yat-sen University
Third Affiliated Hospital, Sun Yat-Sen University

Unknown

Characteristic Study on Chinese Patients With Multiple Sclerosis

Multiple Sclerosis

China
Antisoma Research

Completed

Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia

Leukemia, Myeloid

United States, New Zealand
University of Bologna

Unknown

Adoptive Immunotherapy of High Risk Acute Myeloblastic Leukemia Patients Using Haploidentical Kir Ligand-mismatched Natural Killer Cells

Myeloblastic Leukemia

Italy
Celgene Corporation

Completed

A Phase II Study of Continuous Versus Syncopated Dosing of CC-5013 for the Treatment of Refractory Multiple Myeloma

Multiple Myeloma

United States
Northern Italy Leukemia Group

Completed

Prophylaxis of Fungal Invasive Infections in Leukemia (PROFIL-C)

Invasive Pulmonary Aspergillosis

Italy
Radboud University Medical Center
Bayer

Completed

Phase 1 Study With Sorafenib and Sirolimus

Advanced Solid Tumor | Refractory to Standard Therapies

Netherlands
PETHEMA Foundation
Merck Sharp & Dohme LLC

Completed

AMENO-2: Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors (AMENO-2)

Lymphoma | Leukemia

Spain
Nagoya City University
Kochi University

Completed

Brief Behavioral Therapy for Insomnia (bBT-I) for Depressed Outpatients With Refractory Insomnia

Major Depressive Disorder

Japan
CSL Limited

Completed

Safety, Tolerability and Pharmacokinetics of CSL360 in the Treatment of Acute Myeloid Leukemia

Acute Myeloid Leukemia (AML)

Australia
University of Bologna
Novartis

Unknown

Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias

Myeloproliferative Disorders | Hypereosinophilic Syndrome | Chronic Eosinophilic Leukemia (CEL)

Italy
University of Bologna

Unknown

Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults

Non-Hodgkin's Lymphoma | Acute Lymphoblastic Leukemia

Italy
AstraZeneca

Completed

Safety, Tolerability and PK of AZD1152 in Patients With Relapsed Acute Myeloid Leukaemia (AML)

Acute Myeloid Leukaemia

Japan
University Hospital, Grenoble
French Innovative Leukemia Organisation

Completed

Study About Treatment of Newly Diagnosed Non Cutaneous Peripheral T Cell Lymphoma (LTP)

Peripheral T Cell Lymphoma

France
Vanak Eye Surgery Center

Completed

Ahmed Glaucoma Valve and Single-Plate Molteno Implants in Treatment of Refractory Glaucoma

Refractory Glaucoma

Iran, Islamic Republic of
Celgene Corporation

Terminated

A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Diffuse Large B-cell Lymphoma

United States, Canada, Australia
Istituto Auxologico Italiano
Menarini Group

Completed

Effects of Nebivolol Versus Carvedilol on Cardiopulmonary Function at High Altitude in Healthy Subjects.

Heart Failure | Hypoxia | Altitude

Italy
Yonsei University

Completed

Short-term Ketogenic Diet as Compared With Conventional Long-term Trial in Refractory Infantile Spasms: A Randomized, Controlled Study

Infantile Spasms
Rambam Health Care Campus
Miltenyi Biomedicine GmbH

Unknown

Allogeneic Stem Cell Transplantation in CML With Partial T Cell Depletion

Philadelphia Chromosome-positive Chronic Myelocytic Leukemia

Israel
Nantes University Hospital
Hoffmann-La Roche; French Innovative Leukemia Organisation

Completed

High-dose Chemotherapy With Rituximab for Adults With Aggressive Large B-cell Lymphoma

B-Cell Lymphoma

France
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Efficacy of Gemtuzumab Ozogamicin in Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating MAC-321 in Non-small Cell Lung Cancer Refractory to Platinum-based Therapy

Carcinoma, Non-Small-Cell Lung | Lung Neoplasms

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Comparison of Two Treatments in Intermediate and High-risk Acute Promyelocytic Leukemia (APL) Patients to Assess Efficacy in 1st Hematological Complete Remission and Molecular Remission

Leukemia, Myelocytic, Acute

Search clinical trials for: Refractory Leukemia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations